文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

全球流感病毒、呼吸道合胞病毒、副流感病毒和偏肺病毒的月度活动模式:系统分析

Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis.
PubMed 文献 · Lancet Glob Health · 2019-01-01

该研究汇总2000—2017年文献、在线数据集和未发表数据,纳入246个流感、183个RSV、83个副流感、65个偏肺病毒监测点,计算月度年度平均百分比(AAP)和流行持续时间。流感在温带冬季流行、近赤道季节性减弱;RSV在温带和热带均有季节性,热带始于夏末;模型可预测流感(温带)和RSV(温带及热带)的局部流行月份,预测误差在1个月内。

要点

  • 温带流感冬季流行,近赤道季节性减弱,热带RSV始于夏末。

核心结论

  • 首次提供四种呼吸道病毒逐月全球活动图谱,模型可预测流感(温带)和RSV(温带及热带)的局部流行月份。

研究设计与样本

  • 系统分析,汇总2000年1月1日至2017年12月31日文献、在线数据集和未发表数据,纳入185篇合格文献。
  • 纳入标准要求至少连续12个月实验室确诊数据、检测方法稳定、地理界定明确、至少按月汇总。
  • 计算月度年度平均百分比(AAP)作为病毒活动相对强度,流行持续时间定义为覆盖年度阳性样本75%的最少月数。
  • 利用站点温度和相对湿度建模流感与RSV的月度AAP,并在5°×5°网格预测全球流行月份。
  • 系统评价注册号PROSPERO CRD42018091628。

主要发现

  • 纳入246个流感、183个RSV、83个副流感、65个偏肺病毒监测点。
  • 流感在多数温带站点冬季有明确季节性流行,随距赤道距离减小时间更可变且季节性减弱。
  • RSV在温带和热带均有明确季节性流行,热带始于各半球夏末,多数温带站点冬季达峰。
  • 副流感主要在各半球春季和初夏流行;偏肺病毒在多数温带站点晚冬和春季流行,热带时间更多样。

临床怎么用

  • 季节性信息可用于卫生服务规划、RSV被动预防时机及流感与未来RSV疫苗接种策略。
  • 模型有助于预测当地流感和RSV流行开始月份,指导提前部署防控资源。

局限性

  • 研究基于现有监测数据,部分地区和病毒类型的站点数量有限。
  • 模型预测主要针对温带流感及温带和热带RSV,其他病毒和热带流感预测能力未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus are the most common viruses associated with acute lower respiratory infections in young children (<5 years) and older people (≥65 years). A global report of the monthly activity of these viruses is needed to inform public health strategies and programmes for their control. METHODS: In this systematic analysis, we compiled data from a systematic literature review of studies published between Jan 1, 2000, and Dec 31, 2017; online datasets; and unpublished research data. Studies were eligible for inclusion if they reported laboratory-confirmed incidence data of human infection of influenza virus, respiratory syncytial virus, parainfluenza virus, or metapneumovirus, or a combination of these, for at least 12 consecutive months (or 52 weeks equivalent); stable testing practice throughout all years reported; virus results among residents in well-defined geographical locations; and aggregated virus results at least on a monthly basis. Data were extracted through a three-stage process, from which we calculated monthly annual average percentage (AAP) as the relative strength of virus activity. We defined duration of epidemics as the minimum number of months to account for 75% of annual positive samples, with each component month defined as an epidemic month. Furthermore, we modelled monthly AAP of influenza virus and respiratory syncytial virus using site-specific temperature and relative humidity for the prediction of local average epidemic months. We also predicted global epidemic months of influenza virus and respiratory syncytial virus on a 5° by 5° grid. The systematic review in this study is registered with PROSPERO, number CRD42018091628. FINDINGS: We initally identified 37 335 eligible studies. Of 21 065 studies remaining after exclusion of duplicates, 1081 full-text articles were assessed for eligibility, of which 185 were identified as eligible. We included 246 sites for influenza virus, 183 sites for respiratory syncytial virus, 83 sites for parainfluenza virus, and 65 sites for metapneumovirus. Influenza virus had clear seasonal epidemics in winter months in most temperate sites but timing of epidemics was more variable and less seasonal with decreasing distance from the equator. Unlike influenza virus, respiratory syncytial virus had clear seasonal epidemics in both temperate and tropical regions, starting in late summer months in the tropics of each hemisphere, reaching most temperate sites in winter months. In most temperate sites, influenza virus epidemics occurred later than respiratory syncytial virus (by 0·3 months [95% CI -0·3 to 0·9]) while no clear temporal order was observed in the tropics. Parainfluenza virus epidemics were found mostly in spring and early summer months in each hemisphere. Metapneumovirus epidemics occurred in late winter and spring in most temperate sites but the timing of epidemics was more diverse in the tropics. Influenza virus epidemics had shorter duration (3·8 months [3·6 to 4·0]) in temperate sites and longer duration (5·2 months [4·9 to 5·5]) in the tropics. Duration of epidemics was similar across all sites for respiratory syncytial virus (4·6 months [4·3 to 4·8]), as it was for metapneumovirus (4·8 months [4·4 to 5·1]). By comparison, parainfluenza virus had longer duration of epidemics (6·3 months [6·0 to 6·7]). Our model had good predictability in the average epidemic months of influenza virus in temperate regions and respiratory syncytial virus in both temperate and tropical regions. Through leave-one-out cross validation, the overall prediction error in the onset of epidemics was within 1 month (influenza virus -0·2 months [-0·6 to 0·1]; respiratory syncytial virus 0·1 months [-0·2 to 0·4]). INTERPRETATION: This study is the first to provide global representations of month-by-month activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus. Our model is helpful in predicting the local onset month of influenza virus and respiratory syncytial virus epidemics. The seasonality information has important implications for health services planning, the timing of respiratory syncytial virus passive prophylaxis, and the strategy of influenza virus and future respiratory syncytial virus vaccination. FUNDING: European Union Innovative Medicines Initiative Respiratory Syncytial Virus Consortium in Europe (RESCEU).

来源:Lancet Glob Health,查看原文。版权归原作者所有。

引用

  1. Li Y, Reeves RM, Wang X, et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. 2019. PMID: 31303294. doi:10.1016/S2214-109X(19)30264-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。